Cargando…
P686: REAL-WORLD EFFICACY PROFILE OF ASCIMINIB IN AN ITALIAN, MULTI-RESISTANT CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENT POPULATION
Ejemplares similares
-
P663: MULTICENTER, PROSPECTIVE AND RETROSPECTIVE OBSERVATIONAL COHORT STUDY OF PONATINIB IN PATIENTS WITH CML IN ITALY: LONG-TERM FOLLOW-UP RESULTS OF THE OITI TRIAL
por: Breccia, Massimo, et al.
Publicado: (2023) -
686 A Fishmonger's Tale
por: Mojica, Lysenia, et al.
Publicado: (2014) -
Asciminib for chronic myeloid leukaemia
Publicado: (2022) -
FRI686 Phenotypic Profiling And Molecular Mechanisms In Hyperparathyroidism-jaw Tumor Syndrome
por: Tora, Rana, et al.
Publicado: (2023) -
Significance of the 686 Program for China and for global mental health
por: Good, Byron J., et al.
Publicado: (2012)